Agenus Inc. (AGEN)
Valuation Overview•Is Agenus Inc. Overvalued or Undervalued?
Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Fragile underlying quality score of 39/100; weak margins or elevated debt leverage warrant caution.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: Mixed fundamental profile with offsetting strengths and weaknesses.
Wall Street is highly bullish, projecting significant upside. However, capital return yields remain modest, driven predominantly by aggressive share repurchases.
AGEN struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company demonstrates solid revenue growth (5.2% 3Y CAGR) paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 6.6%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $33.7M | +10.4% | +5.2% | +5.3% | +16.5% | |
| EBITDA | $15.6M | — | +60.6% | — | — | |
| Net Income | $39.2M | +100.1% | — | — | — | |
| EPS (Diluted) | $1.02 | +100.0% | — | — | +58.5% | |
| Free Cash Flow | -$36.0M | +0.0% | +11.4% | -2.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 52.1% | -24.4% | -27.2% | -94.3% |
| Operating Margin | 6.6% | -78.8% | -82.2% | -164.5% |
| Net Margin | 52.2% | -125.6% | -121.9% | -216.4% |
| FCF Margin | -70.7% | -147.5% | -136.7% | -186.4% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $2.10 | $1.02 | -51.4% | ||
| Q1'26 | $-1.27 | $0.56 | +144.1% | ||
| Q4'25 | $2.63 | $1.94 | -26.2% | ||
| Q3'25 | $-0.78 | $-1.00 | -28.2% | ||
| Q2'25 | $-1.61 | $-1.03 | +36.0% | ||
| Q1'25 | $-2.36 | $-2.04 | +13.6% | ||
| Q4'24 | $-2.33 | $-3.08 | -32.2% | ||
| Q3'24 | $-1.44 | $-2.52 | -75.0% |
Total return is -32.9% (1Y), lagging the benchmark by -57.9%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -7.1% | -16.4% | — |
| 1Y | -32.9% | -57.9% | — |
| 3YCAGR | -56.9% | -76.6% | — |
| 5YCAGR | -50.9% | -63.6% | — |
| 10YCAGR | -28.4% | -41.8% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Agenus Inc. (AGEN) valuation, health, and returns.
Based on peer relative multiples, Agenus Inc. appears Cheap versus peers compared to industry peers.
Agenus Inc. has multiple valuation anchors: Peer Relative Fair Value: $13.13 | Wall Street Analyst Target: $7.33 (implying +144.3% upside). A convergence of these signals offers higher conviction.
Agenus Inc. displays weak financial health with a composite quality score of 39/100, supported by a Altman Z-Score of -15.0 (distress zone), Piotroski F-Score of 5/9.
Agenus Inc. does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Agenus Inc.'s current growth trajectory is Accelerating. The company achieved +10.4% 1Y revenue growth and +100.0% 1Y EPS growth, compared to its 3Y revenue CAGR of +5.2%.
Wall Street consensus is Buy based on 11 analysts, beating EPS expectations in 42% of recent quarters with a -1-quarter streak. The consensus price target represents a +144.3% change from current levels.
Investment risks for Agenus Inc. include: -60.8% 1-year max drawdown, high beta (2.17x market volatility), elevated distress risk. Volatility risk is characterized by a beta of 2.17x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.